Pulmonary Ventilation
16
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
1 terminated out of 16 trials
90.0%
+3.5% vs benchmark
13%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
CAvent-Ventilation During Advanced Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest- an Observational Study
Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles
EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade
Evaluation of Chest Wall Motion Symmetry During Ventilation in Healthy Subjects by Optoelectronic Plethysmography
Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient
Distribution of Pulmonary Ventilation With the Modified Pachon Incentive vs. Branded Respiratory Incentive
The Study of Regional Lung Ventilation-perfusion by EIT
Evaluation of Sedation in COVID-19 ARDS
Immuno Nutrition by L-citrulline for Critically Ill Patients
Comparison of Ventilation Tubes Among Anesthetized Pediatrics
Flow Controlled Ventilation (FCV) With the Evone Ventilator and Tritube Versus Volume Controlled Ventilation (VCV)
Ventilatory Muscle Training in Stroke
Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device
Ventilation and Pulmonary Aeration, Electrical Impedance Tomography, Interscalene Brachial Plexus Block
Impact of NaHCO3- on Exercise Hyperpnea
Observing Changes in Ventilation Pattern During Procedural Sedation